Cargando…
From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Wolters Kluwer - Medknow
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933873/ https://www.ncbi.nlm.nih.gov/pubmed/33463558 http://dx.doi.org/10.4103/ijo.IJO_150_21 |
| _version_ | 1783660707957440512 |
|---|---|
| author | Honavar, Santosh G |
| author_facet | Honavar, Santosh G |
| author_sort | Honavar, Santosh G |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7933873 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Wolters Kluwer - Medknow |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79338732021-03-08 From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics Honavar, Santosh G Indian J Ophthalmol Editorial Wolters Kluwer - Medknow 2021-02 /pmc/articles/PMC7933873/ /pubmed/33463558 http://dx.doi.org/10.4103/ijo.IJO_150_21 Text en Copyright: © 2021 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
| spellingShingle | Editorial Honavar, Santosh G From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics |
| title | From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics |
| title_full | From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics |
| title_fullStr | From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics |
| title_full_unstemmed | From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics |
| title_short | From Biologics to Biosimilars and Biobetters – Democratization of High-end Therapeutics |
| title_sort | from biologics to biosimilars and biobetters – democratization of high-end therapeutics |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7933873/ https://www.ncbi.nlm.nih.gov/pubmed/33463558 http://dx.doi.org/10.4103/ijo.IJO_150_21 |
| work_keys_str_mv | AT honavarsantoshg frombiologicstobiosimilarsandbiobettersdemocratizationofhighendtherapeutics |